“…Although plasmas have been extensively investigated for the inactivation of liquid, food, and surface‐borne pathogens, [ 48–57 ] only a handful of studies showing inactivation efficacy of plasmas against airborne pathogens have been conducted, and even less concerning airborne viruses. [ 58,59 ] Previously, the use of cold oxygen plasma in a single‐pass flow tunnel resulted in 3.1, 2, and 2.1 log 10 TCID 50 /ml reductions in human parainfluenza virus type 3 (hPIV‐3), respiratory syncytial virus (RSV), and influenza virus A (H5N2) titers, respectively. [ 60 ] In another study, >95% inactivation of aerosolized MS2 bacteriophage was achieved in ambient air with a plasma power and exposure of 28 W and 0.12 s, respectively.…”